2 terminated, 1 completed, 1 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 2, Completed 1, Recruiting 1 |
| Phase 2 | 2 | Terminated 2 |
Follow Unresectable Leiomyosarcoma: new trials by email Literature Review of Unresectable Leiomyosarcoma trials Research Report on Unresectable Leiomyosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Dedifferentiated Liposarcoma, Metastatic Leiomyosarcoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 30 | 2024-02-06 | 2026-11-04 |
| Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery Avelumab, Trabectedin - Metastatic Leiomyosarcoma, Metastatic Liposarcoma | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 35 | 2017-09-28 | 2022-04-29 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 16 | 2017-03-10 | 2023-08-16 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 151 | 2015-11-30 | 2022-08-23 |
Dermatofibrosarcoma (3) · Histiocytoma, Malignant Fibrous (3) · Leiomyosarcoma (3) · Liposarcoma (3) · Sarcoma, Synovial (3) · Neurofibrosarcoma (2) · Sarcoma (2) · Disorders of Sex Development (1) · Fibrosarcoma (1) · Hemangiosarcoma (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Connective and Soft Tissue (4) · Histiocytoma (3) · Neoplasms, Adipose Tissue (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Fibrous Tissue (3) · Neoplasms, Muscle Tissue (3) · Fibrosarcoma (2) · Neoplasms, Nerve Tissue (2) · Nerve Sheath Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neurofibroma (2) · Neuromuscular Diseases (2)
Doxorubicin (2) · Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · Trabectedin (1) · avelumab (1) · liposomal doxorubicin (1) · pazopanib (1) · peposertib (1) · ribociclib (1) · sapanisertib (1)
National Cancer Institute (NCI) (2) · Fred Hutchinson Cancer Center (1) · OHSU Knight Cancer Institute (1)
United States (4)
Candace L Haddox (1) · Lara E Davis (1) · Seth Pollack (1) · William D Tap (1)
P30CA015704 (1), U10CA180821 (1), UM1CA186709 (1)